Search Within

Darren Richard Feldman

Formats
  1. Journal Article (189)
  2. Meeting Abstract (142)
  3. Book Section (6)
  4. Review (6)
  5. Guidelines (2)
  6. Research Letter (2)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Department of Medicine (349)
  2. Genitourinary Oncology Service (349)
  3. Solid Tumor Oncology Division (349)
  4. Survivorship Research (125)
  5. Surgery (114)
  6. Epidemiology and Biostatistics (112)

More Groups

People
  1. Robert Motzer (158)
  2. George Bosl (86)
  3. Martin Voss (81)
  4. Sujata Patil (81)
  5. Joel Sheinfeld (68)
  6. Chung-Han Lee (55)

More People

Years
  1. 2025 (16)
  2. 2024 (24)
  3. 2023 (20)
  4. 2022 (21)
  5. 2021 (25)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (148)
  2. Urology (13)
  3. Clinical Genitourinary Cancer (11)
  4. Cancer (10)
  5. Clinical Cancer Research (9)
  6. Investigational New Drugs (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (154)
  2. Elsevier Science, Inc. (29)
  3. Elsevier Inc. (28)
  4. Wiley Blackwell (20)
  5. Oxford University Press (18)
  6. American Association for Cancer Research (17)

More Publishers

Results (349)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Matched molecular profiling of cell-free DNA and tumor tissue in patients with advanced clear cell renal cell carcinoma
    Journal Article

    Kotecha, R. R.; Gedvilaite, E.; Ptashkin, R.; Knezevic, A.; Murray, S.; Johnson, I.; Shapnik, N.; Feldman, D. R.; Carlo, M. I.; Shah, N. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Craniocaudal nodal length (CCNL) as a risk-factor for relapse in stage I non-seminomatous germ cell tumors (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Fernandes, M. C.; Funt, S. A.; Bromberg, M.; Knezevic, A.; Nikolovski, I.; Feldman, D. R.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management
    Meeting Abstract

    Truong, H.; Ravichandran, V.; Kemel, Y.; Knezevic, A.; Gleeson, J. P.; Benfante, N.; Bromberg, M.; Bolos, M.; Joseph, G.; Matulewicz, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Building a model to predict the risk of multiple severe neurotoxicities in cancer survivors after cisplatin treatment
    Meeting Abstract

    Nakshatri, S.; Shuey, M.; Shahbazi, M.; Trendowski, M.; Dinh, P. C.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Fung, C.; Kollmannsberger, C. K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term outcomes of adrenal insufficiency (AI) due to anti-PD(L)-1 immune checkpoint inhibitors (ICI) among patients with cancer
    Meeting Abstract

    Nguyen, B.; Shah, N. J.; Knezevic, A.; Newman, S.; Fitzgerald, K. N.; Kotecha, R.; Lee, C. H.; Carlo, M. I.; Aggen, D. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT)
    Meeting Abstract

    Gleeson, J. P.; Harrold, E.; Bromberg, M.; Patel, Z.; Knezevic, A.; Thomas, T.; Ravichandran, V.; Tran, C.; Silber, D.; Carver, B. S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Progression-free survival after second line of therapy (PFS-2) for metastatic clear cell renal cell carcinoma (ccRCC) in patients treated with first-line immunotherapy combinations
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)Lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct patient social media outreach
    Meeting Abstract

    Doe-Tetteh, S. A.; Camp, S. Y.; Crowdis, J.; Noronha, A. M.; Reales, D.; Alano, T.; Viale, A.; Donoghue, M.; Socci, N. D.; Berger, M. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)
    Meeting Abstract

    Zebic, D.; Stockler, M. R.; Martin, A.; Pashankar, F.; Tran, B.; Mazhar, D.; Huddart, R.; Wheater, M.; Walpole, E.; Dunwoodie, E.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save